Koleka Mlisana
 | Bio: | Dr Mlisana is the head of the HIV Vaccine and Pathogenesis Research at the Centre for the AIDS Programme of Research in South Africa (CAPRISA), a research institution within the University of KwaZulu-Natal based at the Nelson R Mandela School of Medicine. Dr Mlisana is also the protocol co-chair for the previously NIH funded Acute HIV Infection Study. Her current research work focuses on HIV pathogenesis and vaccines and she is the site PI for SAAVI (South African AIDS Vaccine Initiative) and HVTN 503 grants. She also was the site project director for the CAPRISA 004 Microbicide trial that used Tenofovir gel.
Dr Mlisana has recently gone back to work as a consultant medical microbiologist in a private pathology laboratory she worked in before; where she focused on HIV education for the clinicians in the private sector in the mid and late 1990s. Her current interests in the field of HIV and AIDS are: HIV prevention – vaccines and microbicide trials, acute HIV infection, HIV in female sex workers; training of healthcare workers in HIV disease management and community education.
|  |
 | e-mail: | mlisanak@ukzn.ac.za | |
 | Address: | Nelson R Mandela School of Medicine
Congella, South Africa
ZA - South Africa | |
Last update: Wednesday, June 22, 2011
|